Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Mar 24, 2009

Premium

Ambry Genetics this week began offering sequence capture for the Illumina Genome Analyzer II or Roche 454 Life Sciences GS FLX Titanium second-generation sequencing platforms.

The Aliso Viejo, Calif.-based CLIA-compliant lab offers the application using custom 385K or pre-designed 2.1M high-density arrays available through Roche NimbleGen. Sequencing can be done in-house at Ambry on the Illumina GA II, or returned to the customer for sequencing on their platform, the company said.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.